Exploring barriers and facilitators to indirect cascade screening for familial hypercholesteremia in a pediatric/parent population

[1]  B. McCrindle,et al.  The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update. , 2022, The Canadian journal of cardiology.

[2]  P. Nathan,et al.  Determinants of surveillance for late effects in childhood cancer survivors: a qualitative study using the Theoretical Domains Framework , 2021, Journal of Cancer Survivorship.

[3]  W. D. Dotson,et al.  Barriers and facilitators for cascade testing in genetic conditions: a systematic review , 2020, European Journal of Human Genetics.

[4]  Sara L Gill,et al.  Qualitative Sampling Methods , 2020, Journal of human lactation : official journal of International Lactation Consultant Association.

[5]  A. Rodday,et al.  Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and Barriers. , 2020, The Canadian journal of cardiology.

[6]  J. Steinberger,et al.  Risk Communication in Families of Children with Familial Hypercholesterolemia: Identifying Motivators and Barriers to Cascade Screening to Improve Diagnosis at a Single Medical Center , 2018, Journal of Genetic Counseling.

[7]  G. Francis,et al.  Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018. , 2018, The Canadian journal of cardiology.

[8]  C. Moorley,et al.  How to appraise qualitative research , 2018, Evidence Based Journals.

[9]  J. Barnett,et al.  Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period , 2018, BMC Medical Research Methodology.

[10]  Jill S. Dolinsky,et al.  Genetic Testing for Familial Hypercholesterolemia , 2018 .

[11]  Jeremy M. Grimshaw,et al.  A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems , 2017, Implementation Science.

[12]  G. Watts,et al.  Patients’ Perceptions and Experiences of Familial Hypercholesterolemia, Cascade Genetic Screening and Treatment , 2015, International Journal of Behavioral Medicine.

[13]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[14]  S. Daniels.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[15]  M. Porteous,et al.  Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative study , 2011, Journal of Community Genetics.

[16]  I. Mesters,et al.  Family communication regarding inherited high cholesterol: why and how do patients disclose genetic risk? , 2007, Social science & medicine.